Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome

Background: Excess circulating endocannabinoids (eCBs) and imbalanced N-acylethanolamines (NAEs) related eCBs abundance could influence dietary weight loss success. We aimed to examine sex differences in the impact of a 3-years Mediterranean diet (MedDiet) intervention on circulating eCBs, NAEs and...

Descripción completa

Detalles Bibliográficos
Autores: Soldevila-Domenech, N. (Natalia)|||/items/a9a56824-9a47-4934-b654-59e82af8d7d9, Pastor, A. (Antoni)|||/items/801e18d6-516a-4d44-9725-8fdf28c1d869, Sala-Vila, A. (Aleix)|||/items/1ad50907-4d92-418e-87a6-5bddb69c29f0, Lázaro, I. (Iolanda)|||/items/f4655c68-f23b-4ad7-8d7d-5bba6fa8b225, Boronat, A. (Anna)|||/items/2ce0dabe-cf89-4687-a927-2a4f60ebc2bc, Muñoz, D. (Daniel)|||/items/d2a2ce0f-ce15-4722-9f26-084329786460, Castañer, O. (Olga)|||/items/177ed76c-c237-4ac1-99b7-445c1b2e49dc, Fagundo, B. (Beatriz)|||/items/a8436f19-9fc9-4bae-9831-ff849ffa56b2, Corella, D. (Dolores)|||/items/edf5ac4d-018f-446d-aa6e-2448c41a1e41, Fernandez-Aranda, F. (Fernando)|||/items/797e1a75-1ed2-4ee6-9666-f6de61f027b7, Martínez-González, M.A. (Miguel Ángel)|||/items/8b591471-4165-4697-8534-cfa0ad5eb1b7, Salas-Salvado, J. (Jordi)|||/items/e2fc08dd-d21f-475b-83fa-157f0b0067e6, Fito, M. (Montserrat)|||/items/7de631e9-926b-4b1a-9964-0c0ca699df6b, Torre, R. (Rafael) de la|||/items/8ffc37a7-8bbf-4973-8257-72f8c379cd46
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dnet:dadun_______::89838f7892d5ac078c3341a0d915febf
Acceso en línea:https://hdl.handle.net/10171/124507
Access Level:acceso abierto
Palabra clave:2-arachidonoylglycerol (2-AG)
Mediterranean diet
Anandamide (AEA)
Endocannabinoids
Insulin resistance
Metabolic syndrome
Sex differences
Weight loss
id ES_4ef72ff7bc1739c93e8be8bdbb4052f6
oai_identifier_str oai:dnet:dadun_______::89838f7892d5ac078c3341a0d915febf
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
title Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
spellingShingle Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
Soldevila-Domenech, N. (Natalia)|||/items/a9a56824-9a47-4934-b654-59e82af8d7d9
2-arachidonoylglycerol (2-AG)
Mediterranean diet
Anandamide (AEA)
Endocannabinoids
Insulin resistance
Metabolic syndrome
Sex differences
Weight loss
title_short Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
title_full Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
title_fullStr Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
title_full_unstemmed Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
title_sort Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
dc.creator.none.fl_str_mv Soldevila-Domenech, N. (Natalia)|||/items/a9a56824-9a47-4934-b654-59e82af8d7d9
Pastor, A. (Antoni)|||/items/801e18d6-516a-4d44-9725-8fdf28c1d869
Sala-Vila, A. (Aleix)|||/items/1ad50907-4d92-418e-87a6-5bddb69c29f0
Lázaro, I. (Iolanda)|||/items/f4655c68-f23b-4ad7-8d7d-5bba6fa8b225
Boronat, A. (Anna)|||/items/2ce0dabe-cf89-4687-a927-2a4f60ebc2bc
Muñoz, D. (Daniel)|||/items/d2a2ce0f-ce15-4722-9f26-084329786460
Castañer, O. (Olga)|||/items/177ed76c-c237-4ac1-99b7-445c1b2e49dc
Fagundo, B. (Beatriz)|||/items/a8436f19-9fc9-4bae-9831-ff849ffa56b2
Corella, D. (Dolores)|||/items/edf5ac4d-018f-446d-aa6e-2448c41a1e41
Fernandez-Aranda, F. (Fernando)|||/items/797e1a75-1ed2-4ee6-9666-f6de61f027b7
Martínez-González, M.A. (Miguel Ángel)|||/items/8b591471-4165-4697-8534-cfa0ad5eb1b7
Salas-Salvado, J. (Jordi)|||/items/e2fc08dd-d21f-475b-83fa-157f0b0067e6
Fito, M. (Montserrat)|||/items/7de631e9-926b-4b1a-9964-0c0ca699df6b
Torre, R. (Rafael) de la|||/items/8ffc37a7-8bbf-4973-8257-72f8c379cd46
author Soldevila-Domenech, N. (Natalia)|||/items/a9a56824-9a47-4934-b654-59e82af8d7d9
author_facet Soldevila-Domenech, N. (Natalia)|||/items/a9a56824-9a47-4934-b654-59e82af8d7d9
Pastor, A. (Antoni)|||/items/801e18d6-516a-4d44-9725-8fdf28c1d869
Sala-Vila, A. (Aleix)|||/items/1ad50907-4d92-418e-87a6-5bddb69c29f0
Lázaro, I. (Iolanda)|||/items/f4655c68-f23b-4ad7-8d7d-5bba6fa8b225
Boronat, A. (Anna)|||/items/2ce0dabe-cf89-4687-a927-2a4f60ebc2bc
Muñoz, D. (Daniel)|||/items/d2a2ce0f-ce15-4722-9f26-084329786460
Castañer, O. (Olga)|||/items/177ed76c-c237-4ac1-99b7-445c1b2e49dc
Fagundo, B. (Beatriz)|||/items/a8436f19-9fc9-4bae-9831-ff849ffa56b2
Corella, D. (Dolores)|||/items/edf5ac4d-018f-446d-aa6e-2448c41a1e41
Fernandez-Aranda, F. (Fernando)|||/items/797e1a75-1ed2-4ee6-9666-f6de61f027b7
Martínez-González, M.A. (Miguel Ángel)|||/items/8b591471-4165-4697-8534-cfa0ad5eb1b7
Salas-Salvado, J. (Jordi)|||/items/e2fc08dd-d21f-475b-83fa-157f0b0067e6
Fito, M. (Montserrat)|||/items/7de631e9-926b-4b1a-9964-0c0ca699df6b
Torre, R. (Rafael) de la|||/items/8ffc37a7-8bbf-4973-8257-72f8c379cd46
author_role author
author2 Pastor, A. (Antoni)|||/items/801e18d6-516a-4d44-9725-8fdf28c1d869
Sala-Vila, A. (Aleix)|||/items/1ad50907-4d92-418e-87a6-5bddb69c29f0
Lázaro, I. (Iolanda)|||/items/f4655c68-f23b-4ad7-8d7d-5bba6fa8b225
Boronat, A. (Anna)|||/items/2ce0dabe-cf89-4687-a927-2a4f60ebc2bc
Muñoz, D. (Daniel)|||/items/d2a2ce0f-ce15-4722-9f26-084329786460
Castañer, O. (Olga)|||/items/177ed76c-c237-4ac1-99b7-445c1b2e49dc
Fagundo, B. (Beatriz)|||/items/a8436f19-9fc9-4bae-9831-ff849ffa56b2
Corella, D. (Dolores)|||/items/edf5ac4d-018f-446d-aa6e-2448c41a1e41
Fernandez-Aranda, F. (Fernando)|||/items/797e1a75-1ed2-4ee6-9666-f6de61f027b7
Martínez-González, M.A. (Miguel Ángel)|||/items/8b591471-4165-4697-8534-cfa0ad5eb1b7
Salas-Salvado, J. (Jordi)|||/items/e2fc08dd-d21f-475b-83fa-157f0b0067e6
Fito, M. (Montserrat)|||/items/7de631e9-926b-4b1a-9964-0c0ca699df6b
Torre, R. (Rafael) de la|||/items/8ffc37a7-8bbf-4973-8257-72f8c379cd46
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv 2-arachidonoylglycerol (2-AG)
Mediterranean diet
Anandamide (AEA)
Endocannabinoids
Insulin resistance
Metabolic syndrome
Sex differences
Weight loss
topic 2-arachidonoylglycerol (2-AG)
Mediterranean diet
Anandamide (AEA)
Endocannabinoids
Insulin resistance
Metabolic syndrome
Sex differences
Weight loss
description Background: Excess circulating endocannabinoids (eCBs) and imbalanced N-acylethanolamines (NAEs) related eCBs abundance could influence dietary weight loss success. We aimed to examine sex differences in the impact of a 3-years Mediterranean diet (MedDiet) intervention on circulating eCBs, NAEs and their precursor fatty acids, and to analyze the interplay between changes in eCBs or NAEs ratios, insulin resistance and the achievement of clinically meaningful weight reductions. Methods: Prospective cohort study in a subsample of N = 105 participants (54.3% women; 65.6 ± 4.6 years) with overweight or obesity and metabolic syndrome that underwent a 3-years MedDiet intervention (PREDIMED-Plus study). Plasma eCBs and NAEs, including 2-arachidonoylglycerol (2-AG), anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), fatty acids, diet, glycemic homeostasis (including the assessment of insulin resistance-HOMA-IR), and cardiovascular risk markers were monitored (at 0-6-12-36 months). Results: Mediterranean diet adherence increased in both sexes and remained high during the 3 years of follow-up. Reductions in body weight, glycemic and cardiovascular parameters were larger in men than in women. Women presented higher concentrations of NAEs than men throughout the study. In both sexes, AEA and other NAEs (including OEA, and PEA) decreased after 6 months (for AEA: -4.9%), whereas the ratio OEA/AEA increased after 1 year (+5.8%). Changes in 2-AG (-3.9%) and the ratio OEA/PEA (+8.2%) persisted over the 3 years of follow-up. In women, 6-months changes in AEA (OR = 0.65) and the ratio OEA/AEA (OR = 3.28) were associated with the achievement of 8% weight reductions and correlated with HOMA-IR changes (r = 0.29 and r = -0.34). In men, OEA/PEA changes were associated with 8% weight reductions (OR = 2.62) and correlated with HOMA-IR changes (r = -0.32). Conclusion: A 3-years MedDiet intervention modulated plasma concentrations of eCBs and NAEs. Changes in AEA and in the relative abundance of NAEs were associated with clinically meaningful weight reductions. However, marked sex differences were identified in eCBs and NAEs, as well as in the efficacy of the intervention in terms of glycemic and cardiovascular parameters, which could be related to post-menopause alterations in glucose metabolism. These findings support a sex-balanced research strategy for a better understanding of the mechanisms underlying the regulation of body weight loss.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/124507
url https://hdl.handle.net/10171/124507
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers Media S.A.
publisher.none.fl_str_mv Frontiers Media S.A.
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407790034845696
spelling Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndromeSoldevila-Domenech, N. (Natalia)|||/items/a9a56824-9a47-4934-b654-59e82af8d7d9Pastor, A. (Antoni)|||/items/801e18d6-516a-4d44-9725-8fdf28c1d869Sala-Vila, A. (Aleix)|||/items/1ad50907-4d92-418e-87a6-5bddb69c29f0Lázaro, I. (Iolanda)|||/items/f4655c68-f23b-4ad7-8d7d-5bba6fa8b225Boronat, A. (Anna)|||/items/2ce0dabe-cf89-4687-a927-2a4f60ebc2bcMuñoz, D. (Daniel)|||/items/d2a2ce0f-ce15-4722-9f26-084329786460Castañer, O. (Olga)|||/items/177ed76c-c237-4ac1-99b7-445c1b2e49dcFagundo, B. (Beatriz)|||/items/a8436f19-9fc9-4bae-9831-ff849ffa56b2Corella, D. (Dolores)|||/items/edf5ac4d-018f-446d-aa6e-2448c41a1e41Fernandez-Aranda, F. (Fernando)|||/items/797e1a75-1ed2-4ee6-9666-f6de61f027b7Martínez-González, M.A. (Miguel Ángel)|||/items/8b591471-4165-4697-8534-cfa0ad5eb1b7Salas-Salvado, J. (Jordi)|||/items/e2fc08dd-d21f-475b-83fa-157f0b0067e6Fito, M. (Montserrat)|||/items/7de631e9-926b-4b1a-9964-0c0ca699df6bTorre, R. (Rafael) de la|||/items/8ffc37a7-8bbf-4973-8257-72f8c379cd462-arachidonoylglycerol (2-AG)Mediterranean dietAnandamide (AEA)EndocannabinoidsInsulin resistanceMetabolic syndromeSex differencesWeight lossBackground: Excess circulating endocannabinoids (eCBs) and imbalanced N-acylethanolamines (NAEs) related eCBs abundance could influence dietary weight loss success. We aimed to examine sex differences in the impact of a 3-years Mediterranean diet (MedDiet) intervention on circulating eCBs, NAEs and their precursor fatty acids, and to analyze the interplay between changes in eCBs or NAEs ratios, insulin resistance and the achievement of clinically meaningful weight reductions. Methods: Prospective cohort study in a subsample of N = 105 participants (54.3% women; 65.6 ± 4.6 years) with overweight or obesity and metabolic syndrome that underwent a 3-years MedDiet intervention (PREDIMED-Plus study). Plasma eCBs and NAEs, including 2-arachidonoylglycerol (2-AG), anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), fatty acids, diet, glycemic homeostasis (including the assessment of insulin resistance-HOMA-IR), and cardiovascular risk markers were monitored (at 0-6-12-36 months). Results: Mediterranean diet adherence increased in both sexes and remained high during the 3 years of follow-up. Reductions in body weight, glycemic and cardiovascular parameters were larger in men than in women. Women presented higher concentrations of NAEs than men throughout the study. In both sexes, AEA and other NAEs (including OEA, and PEA) decreased after 6 months (for AEA: -4.9%), whereas the ratio OEA/AEA increased after 1 year (+5.8%). Changes in 2-AG (-3.9%) and the ratio OEA/PEA (+8.2%) persisted over the 3 years of follow-up. In women, 6-months changes in AEA (OR = 0.65) and the ratio OEA/AEA (OR = 3.28) were associated with the achievement of 8% weight reductions and correlated with HOMA-IR changes (r = 0.29 and r = -0.34). In men, OEA/PEA changes were associated with 8% weight reductions (OR = 2.62) and correlated with HOMA-IR changes (r = -0.32). Conclusion: A 3-years MedDiet intervention modulated plasma concentrations of eCBs and NAEs. Changes in AEA and in the relative abundance of NAEs were associated with clinically meaningful weight reductions. However, marked sex differences were identified in eCBs and NAEs, as well as in the efficacy of the intervention in terms of glycemic and cardiovascular parameters, which could be related to post-menopause alterations in glucose metabolism. These findings support a sex-balanced research strategy for a better understanding of the mechanisms underlying the regulation of body weight loss.Frontiers Media S.A.Dadun. Depósito Académico Digital Universidad de Navarra20222022-01-0120222022-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/124507reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dnet:dadun_______::89838f7892d5ac078c3341a0d915febf2026-06-21T12:47:57Z
score 15,811543